{"description":"Time in weeks from the date of Complete Response (CR) or Partial Response (PR), whichever occurs earlier, to the date of discontinuation of study. RECIST guidelines:(Response evaluation criteria in solid tumors, version 1.0)","paramType":"NUMBER","reportingStatus":"NOT_POSTED","timeFrame":"Time from first documentation of Complete or Partial Response, whichever occurs earlier, to discontinuation of the study drug (maximum treatment period of 309 days (44 weeks)","title":"Duration of Objective Tumor Response (OTR)","type":"SECONDARY","unitOfMeasure":"Time in weeks"}